These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6356085)

  • 21. The emperor's new clothes or the current practice of clinical trials for multiple myeloma in the USA.
    Ballester O
    Cancer Invest; 2008 Jun; 26(5):445-7. PubMed ID: 18568765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solitary plasmacytoma of bone--a rare disorder with an unusual evolution.
    Ganjoo RK; Malpas JS; Plowman PN
    Postgrad Med J; 1993 Feb; 69(808):153-4. PubMed ID: 8506201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lenalidomide and its role in the management of multiple myeloma.
    Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple myeloma in the era of novel agents.
    Dimopoulos MA; Attal M
    Semin Hematol; 2009 Apr; 46(2):107-9. PubMed ID: 19389493
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple myeloma: current management.
    Alexanian R; Barlogie B
    Tex Med; 1985 Oct; 81(10):24-6. PubMed ID: 4060076
    [No Abstract]   [Full Text] [Related]  

  • 26. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of solitary bone plasmacytoma and bone remineralisation with novel biological agents leading to new bone formation - a case series.
    Blum A; Bazou D; Ting KR; Bianchi G; Mahandran M; Mahandran H; Eustace S; Richardson PG; O'Gorman P
    Br J Haematol; 2021 May; 193(4):e36-e38. PubMed ID: 33748981
    [No Abstract]   [Full Text] [Related]  

  • 28. [Are drug combinations useful in multiple myeloma?].
    Pavlovsky S
    Sangre (Barc); 1984; 29(5):872-5. PubMed ID: 6523339
    [No Abstract]   [Full Text] [Related]  

  • 29. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bortezomib in relapsed multiple myeloma complicated by extramedullary plasmacytomas.
    Hughes M; Micallef-Eynaud P
    Clin Lab Haematol; 2006 Aug; 28(4):267-9. PubMed ID: 16898968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case.
    Katodritou E; Kartsios C; Gastari V; Verrou E; Mihou D; Banti A; Lazaraki G; Lazaridou A; Kaloutsi V; Zervas K
    Leuk Res; 2008 Feb; 32(2):339-41. PubMed ID: 17560647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma presenting as plasmacytoma of the base of the skull.
    Alegre A; Tomás JF; Pinilla I; Gil-Fernández JJ; Fernández-Rañada JM
    Am J Hematol; 1996 May; 52(1):60-1. PubMed ID: 8638614
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results, failures and perspectives in therapy of multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
    Terpos E; Rezvani K; Basu S; Milne AE; Rose PE; Scott GL; Rahemtulla A; Samson D; Apperley JF
    Eur J Haematol; 2005 Nov; 75(5):376-83. PubMed ID: 16191086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous metastatic plasmacytomas with tropism for a previously injured limb.
    Pereira MA; Baudrier T; Costa A; Magalhães J; Azevedo F
    Dermatol Online J; 2008 Sep; 14(9):16. PubMed ID: 19061598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combo drug therapy beneficial for new cases of multiple myeloma.
    Health News; 2006 Feb; 12(2):9. PubMed ID: 16456922
    [No Abstract]   [Full Text] [Related]  

  • 37. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 38. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma.
    Stölting T; Knauerhase H; Klautke G; Kundt G; Fietkau R
    Strahlenther Onkol; 2008 Sep; 184(9):465-72. PubMed ID: 19016025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel agents in myeloma: an exciting saga.
    Mark T; Niesvizky R; Coleman M
    Cancer; 2009 Jan; 115(2):236-42. PubMed ID: 19025986
    [No Abstract]   [Full Text] [Related]  

  • 40. Thalidomide with continuous low-dose dexamethasone for multiple myeloma.
    Gardyn J
    J Clin Oncol; 2005 Feb; 23(6):1323. PubMed ID: 15718336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.